Cristal Therapeutics (@cristaltherap) / Twitter
Cristal Therapeutics Company Profile: Valuation & Investors | PitchBook
Cristal Therapeutics appoints Dr Werner Cautreels as Chairman of the Board and Andre Verwei as CFO — Thuja
Cristal Therapeutics Announces a Publication In 'Chemical Science' On CliCr® Technology Platform, Comprising a New Class of Superior Copper Free Click Reagents for Conjugation of Small Molecules, Biologics, Nanoparticles and Other Moieties
CriPec® Platform to Products
Dr. Axel Mescheder appointed CEO of Cristal Therapeutics as focus intensifies on proprietary oncology nanomedicine pipeline - Utrecht Holdings
Is Cristal Therapeutics late reporting EU clinical trials?
Cristal Therapeutics | Brightlands Maastricht Health Campus - YouTube
Portfolio-Cristal Therapeutics — Thuja
20150924 smb cristal therapeutics jeroen tonnaer
€2.5 million grant awarded to biopharmaceutical firm | Scientist Live
LSX World Congress 2020 Presentations - Cristal Therapeutics - YouTube
Cristal Therapeutics CriPec® Oligonucleotides | EU-Japan Technology Transfer Helpdesk
Cristal Therapeutics raises €12.8 million in new financing round to advance novel medicines against cancer - Brightlands Venture Partners
Intravacc y Cristal Therapeutics se unen para promover nuevas plataformas de vacunas | PlantaDoce
Cristianne Rijcken and Herman Kingma | Brightlands
Cristal Therapeutics empieza la fase I del ensayo clínico con la nanomedicina CriPec® docetaxel en pacientes con tumores sólidos – NANOMED Spain
Dr. Istvan Udvaros joins Cristal Therapeutics as New Chief Medical Officer - Brightlands Venture Partners
20150924 smb cristal therapeutics jeroen tonnaer
Portfolio-Cristal Therapeutics — Thuja
Cristal Therapeutics: Contact Details and Business Profile
CR interview
Intravacc and Cristal Therapeutics announce a strategic collaboration
